This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NRC OKs Exelon Takeover of Constellation: Hot Trends

NEW YORK ( TheStreet) -- Exelon (EXC - Get Report) is trending Friday as the Nuclear Regulatory Commission approved the company's proposed $7.9 billion takeover of Constellation Energy Group (CEG).

The NRC said staff and management at Constellation Energy Nuclear Group's plants would remain unchanged when Exelon takes over. The deal has already been approved by the Justice Department, both companies' shareholders and New York and Texas regulators.

Constellation's nuclear division operates reactors in Maryland and New York, and both companies own plants in Texas, where Constellation also markets power and gas. Maryland regulators are expected to announce whether the state will give approval to the deal Friday.

Anglo-American is another poplar search as the mining company posted record operating profit for 2011 on strength from its coal and diamond operations.

The company reported operating profit of $11.1 billion, a 14% increase from a year before. The company noted three major projects completed in 2011 -- a South African iron ore mine, expansion of a Chilean copper mine and nickel operations in Brazil. The company also reported operating profit for its biggest sector -- iron ore and manganese -- rose 23%.

Anglo American said its long-term outlook for its diversified mix of commodities remains strong.

Qnexa is trending as the diet drug is being reviewed by the Federal Drug Administration after the agency rejected the drug in 2010.

The FDA, which rejected the drug amid safety concerns, including risk of birth defects and cardiovascular problems, is now being presented with additional data from the drug's manufacturer Vivus (VVUS - Get Report). If the FDA approves the drug, it will be the first new prescription diet pill in 13 years. The FDA is expected to release its analysis of the new data on Qnexa on Friday.

The chatter on Main Street (a.k.a. Google, Yahoo! and other search sites) is always of interest to investors on Wall Street. Thus, each day, TheStreet compiles the stories that are trending on the Web, and highlights the news that could make stocks move.

-- Written by Brittany Umar.
Brittany joined TV in November 2006 after completing a degree in Journalism and Media Studies at Rutgers College. Previously, Brittany interned at the local ABC affiliate in New York City WABC-TV 7 where she helped research and produce On Your Side, a popular consumer advocacy segment.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
EXC $27.85 1.98%
VVUS $1.28 2.40%
AAPL $117.34 -0.81%
FB $107.12 2.76%
GOOG $767.04 3.29%


Chart of I:DJI
DOW 17,888.35 +168.43 0.95%
S&P 500 2,102.63 +22.22 1.07%
NASDAQ 5,156.3060 +47.64 0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs